Multicomponent therapeutics for networked systems
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Therapeutic regimens that comprise more than one active ingredient are commonly used in clinical medicine. Despite this, most drug discovery efforts search for drugs that are composed of a single chemical entity. A focus in the early drug discovery process on identifying and optimizing the activity of combinations of molecules can result in the identification of more effective drug regimens. A systems perspective facilitates an understanding of the mechanism of action of such drug combinations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“combinations of chemical agents (or manipulations such as those of transcription factors that affect multiple steps in a pathway [1906] or modulation of multiple gene products [2311], or both [2312,2313]) will be far more efficacious, for instance in modulating iron-catalysed oxidative stress and its sequelae, than will be the use of 'magic bullet' single agents.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1705]
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 1×
“There have been attempts to systematize a set of principles that can account for combination drugs that exist toda”
BackgroundLessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundBlume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Transcriptional Regulatory Networks in Saccharomyces cerevisiae
Lee, T. I., Rinaldi, N. J., Robert, F., Odom, D. T., Bar-Joseph, Z., Gerber, G. K., Hannett, N. M., Harbison, C. T., Thompson, C. M., Simon, I., et al. (2002) · Science · doi:10.1126/science.1075090 · Cited by 2,956
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419 · cited 1×
“Numerous researchers have attempted to provide an unambiguous framework for the calculation of additive effects between compounds; these approaches are reviewed comprehensively elsewher”
BackgroundSystematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Self-citation
Research works printed but not linked: 2
- Ehrlich, P. Chemotherapeutics: scientific principles, methods and results. Lancet 2, 445–451 (1913).
- Albert, A. Selective Toxicity (Methuen & Co., London, 1968).
Cited by
Items 701–799 of 799
Using Chemical Structure as Probes for Biological Networks
Nigsch, F. (2011) · Wiley eBooks · doi:10.1002/9781118131411.ch9
Desenvolvimento de filmes de desintegração oral para liberação de compostos bioativos
Borges, J. G. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.74.2013.tde-10072013-091914 · Cited by 3
Quantitative analysis of adenoviral vector modification of a cytokine-mediated cell death decision
Miller, K. E. (2006) · DSpace@MIT (Massachusetts Institute of Technology)
Trân, Q.-N., Andreev, V., & Fernández, A. (2012) · IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) · doi:10.1109/bibmw.2012.6470297
“Consequently, scientists are advocating molecular therapies based on a multi-pronged attack on the tumor [4], [5], [6], [7], [8].”
BackgroundCountering core and co-morbid symptoms of affective disorders: Complementary multi-target strategies
Millan, M. J. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.10.007
Development of a multi-component drug from turmeric using central composite design
Zhang, X., Han, S., Li, Y., & Jiang, J. (2014) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-014-1439-5
“Multi-component drugs that consist of several active compounds [4] can be more efficacious for complex diseases.”
BackgroundMultitarget Control of Drug Impact: A Therapeutic Imperative in Cancer Systems Biology
Fernández, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-16850-0_13
Targeted Synergism Effects of the Combined Active Constituents of Yinchenhao Tang
Wang, X., Zhang, A., Sun, H. J., & Sun, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803117-9.00017-2
Synthesis and Antimicrobial Activity of Benzo[H][1,6]Naphthyridine Derivatives
Raghunath, B. T., & Balasaheb, P. P. (2016) · Journal of Organic & Inorganic Chemistry · doi:10.21767/2472-1123.100001
Jogiraju, H. (2013) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Genetic and Environmental Contributions to Human Longevity
Awofala, A. A., & Ogundele, O. E. (2016) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.202636
Fernández, A. (2016) · Soft and biological matter · doi:10.1007/978-3-319-30852-4_12
The Optimal Design of Pharmacological Experiments
Kenakin, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407663-1.00008-9
Développement d'une méthode pour la détection de cibles secondaires de ligands
Rasolohery, I. (2016) · theses.fr (ABES) · doi:10.70675/eefe2847z3de0z4d25zab7az64f71f8a563c
Silvers, M. A. (2014) · Louisiana State University · doi:10.31390/gradschool_dissertations.820
Davinelli, S. (2014) · Archivio Istituzionale della Ricerca - Università degli Studi del Molise
Bifunctional Vitamin D Hybrid Molecules
Gleason, J. L., & White, J. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00089-4
How to Design Phase I Trials in Oncology
Carter, L., O’Brien, C., Dean, E. J., & Cook, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-71324-3_10
In silico strategies to study polypharmacology of G-protein-coupled receptors
Hajjo, R. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xtc7-2969
Binding-Site Match Maker (BSMM): A Computational Method for the Design of Multi-Target Ligands
Zhou, J., & Wu, J. H. (2020) · Molecules · doi:10.3390/molecules25081821
“Studies that seek to achieve the synergistic e ff ects by one agent against multiple targets (referred to as multi-target ligands) or a combination of multiple individual agents have been emerging [2–4].”
BackgroundSynergistic Effect of Curcumin: A Review
Kriplani, P., & Guarve, K. (2020) · Current Bioactive Compounds · doi:10.2174/1573407216999200612103042
Combined Effects of Plant Extracts on Ovarian Cell Functioning
Nath, S., Kádasi, A., Großmann, R., Kolesárová, A., Talukdar, A. D., Sirotkin, A. V., & Choudhury, M. D. (2021) · Springer eBooks · doi:10.1007/978-981-15-8127-4_43
Dean, Z. (2019) · Deep Blue (University of Michigan) · doi:10.13140/rg.2.2.29108.50560 · Cited by 1
Mhango, I. (2017) · Nelson Mandela University Research Repository
Onyebuchi, U. C. (2017) · Nelson Mandela University Research Repository
Chalcone and curcumin hybrids of indole propargylamines as multifunctional neuroprotective agents
Musakwa, L. (2020) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Fulfilling a Therapeutic Imperative in Cancer Treatment: Control of Multi-target Drug Impact
Fernández, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-11792-3_10
Gorbunova, A. Y., Sannikova, E. P., Gubaidullin, I. I., Ignatova, O. M., Kopaeva, M. Y., Bulushova, N. V., & Kozlov, D. G. (2021) · Biotekhnologiya · doi:10.21519/0234-2758-2021-37-6-74-83
Morel, C. M. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13328959.14692059
Álvarez-Córdoba, M., Reche-López, D., Cilleros-Holgado, P., Talaverón-Rey, M., Villalón-García, I., Povea-Cabello, S., Suarez-Rivero, J. M., Suárez-Carrillo, A., Munuera-Cabeza, M., Piñero-Pérez, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1629815/v1
Faculty Opinions recommendation of Combinatorial drug discovery in nanoliter droplets.
Djurić, S. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733450002.793549194
Petersen, O. H. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717247952.792502902
Investigating the Quantitative Trait Loci Contributing to Individual Variation in Drug Response
Roberts, C. A. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17014628
“outcome and a network style treatment approach may present a better alternative (Hopkins, 2008; Keith et al., 2005).”
BackgroundSinger, D. S. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717950217.793455470
Álvarez-Córdoba, M., Reche-López, D., Cilleros-Holgado, P., Talaverón-Rey, M., Villalón-García, I., Povea-Cabello, S., Suarez-Rivero, J. M., Suárez-Carrillo, A., Munuera-Cabeza, M., Piñero-Pérez, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1629815/v2
Álvarez-Córdoba, M., Reche-López, D., Cilleros-Holgado, P., Talaverón-Rey, M., Villalón-García, I., Povea-Cabello, S., Suarez-Rivero, J. M., Suárez-Carrillo, A., Munuera-Cabeza, M., Piñero-Pérez, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1629815/v3
Editorial on the Special Issue: “Multidrug Combinations”
Vale, N. (2022) · Biomolecules · doi:10.3390/biom12060812
Álvarez-Córdoba, M., Reche-López, D., Cilleros-Holgado, P., Talaverón-Rey, M., Villalón-García, I., Povea-Cabello, S., Suarez-Rivero, J. M., Suárez-Carrillo, A., Munuera-Cabeza, M., Piñero-Pérez, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1629815/v4
The optimal design of pharmacological experiments
Kenakin, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99289-3.00014-2
Innovative pharmaceutical strategies for niclosamide repositioning
Barbosa, E. J. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2022.tde-30112022-110043
A comparative study on psychiatric disorders: Identification of shared pathways and common agents
Kuzudisli, C., & Bakır-Güngör, B. (2022) · Innovations in Intelligent Systems and Applications Conference (ASYU) · doi:10.1109/asyu56188.2022.9925523
“However, studies focusing on single disorders are challenged and not very effective in many cases, especially regarding multi-factorial diseases [4,5], one of which is psychiatric disorders.”
BackgroundDrug discovery: Standing on the shoulders of giants
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00001-8
Wang, J., Meng, J., Zhu, J., Li, S., Qiu, T., Wang, W., Ding, J., Li, K., & Liu, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95388-7.00026-7
Hand-in-glove Effect of Piperine in Anti-cancer Formulations
Kumar, J., Kriplani, P., & Guarve, K. (2023) · Current Functional Foods · doi:10.2174/2666862901666230727104158
Tawfeek, H. N., Abdelmoez, A., Dahlous, K. A., Youssif, B. G. M., Bräse, S., Rissanen, K. T., Nieger, M., & El‐Sheref, E. M. (2024) · RSC Advances · doi:10.1039/d4ra02531h
Cavallo, C., Hoch, M., & Gupta, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-0157-5_10
Tosun, N. G. (2024) · International Advanced Researches and Engineering Journal · doi:10.35860/iarej.1348930
“The derivation of this method from the law of mass action has made it more preferred in practical applications [14-15].”
MethodEfficacy and Safety of Multitarget Therapy for Lupus Nephritis: A Network Meta-AnalysisPreprint
Zhang, L., Liu, Y., Su, S., Liu, C., & Dong, D. F. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5160376
Challenges in Computational Drug-Drug Interaction Prediction: A Survey
Tuama, M. H., Najm, S. M., & Lakizadeh, A. (2025) · Ingénierie des systèmes d information · doi:10.18280/isi.300623
Miri, Z., Elhami, S., Zare-Shahabadi, V., & Jahromi, H. J. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.126927
A dual granular balanced deep forest model for effective drug combination prediction
Gong, Z., Li, R., Liu, K., Xu, Y., Bo, X., & He, S. (2026) · iScience · doi:10.1016/j.isci.2026.116014
He, J., Wang, L., Zhang, Y., & Wang, S. (2025) · Animals · doi:10.3390/ani15233396
“While such systems allow detailed dissection of molecular events, they cannot replicate baicalin’ s pharmacokinetic behavior in vivo or its complex crosstalk with a fully integrated immune system [22].”
Wrapper Drugs as Therapeutic Editors of Side Effects
Fernández, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-11792-3_12
Fernández, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-16850-0_12
Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer's Disease
der Schyf, C. J. V., Geldenhuys, W. J., & Youdim, M. B. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_17 · Cited by 1
Srithanyarat, T., Taoma, K., Sutthibutpong, T., Ruengjitchatchawalya, M., Liangruksa, M., & Laomettachit, T. (2024) · Figshare · doi:10.6084/m9.figshare.26687073
Hoch, M., Smita, S., Cesnulevicius, K., Schultz, M., Lescheid, D., Wolkenhauer, O., & Gupta, S. K. (2024) · Figshare · doi:10.6084/m9.figshare.26578148
Srithanyarat, T., Taoma, K., Sutthibutpong, T., Ruengjitchatchawalya, M., Liangruksa, M., & Laomettachit, T. (2024) · Figshare · doi:10.6084/m9.figshare.26687076
Álvarez-Córdoba, M., Reche-López, D., Cilleros-Holgado, P., Talaverón-Rey, M., Villalón-García, I., Povea-Cabello, S., Suárez-Rivero, J. M., Suárez-Carrillo, A., Munuera-Cabeza, M., Piñero-Pérez, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20462160
Srithanyarat, T., Taoma, K., Sutthibutpong, T., Ruengjitchatchawalya, M., Liangruksa, M., & Laomettachit, T. (2024) · Figshare · doi:10.6084/m9.figshare.26687070
Srithanyarat, T., Taoma, K., Sutthibutpong, T., Ruengjitchatchawalya, M., Liangruksa, M., & Laomettachit, T. (2024) · Figshare · doi:10.6084/m9.figshare.25322849
Hoch, M., Smita, S., Cesnulevicius, K., Schultz, M., Lescheid, D., Wolkenhauer, O., & Gupta, S. K. (2024) · Figshare · doi:10.6084/m9.figshare.26578145
Srithanyarat, T., Taoma, K., Sutthibutpong, T., Ruengjitchatchawalya, M., Liangruksa, M., & Laomettachit, T. (2024) · Figshare · doi:10.6084/m9.figshare.25322975
Hoch, M., Smita, S., Cesnulevicius, K., Schultz, M., Lescheid, D., Wolkenhauer, O., & Gupta, S. K. (2024) · Figshare · doi:10.6084/m9.figshare.26578151
Srithanyarat, T., Taoma, K., Sutthibutpong, T., Ruengjitchatchawalya, M., Liangruksa, M., & Laomettachit, T. (2024) · Figshare · doi:10.6084/m9.figshare.26687067
Fang, P. (2024) · Qucosa (Saxon State and University Library Dresden)
(12673215), E. W. (2023) · Research Online (University of Wollongong)
Wang, L., Sun, L., Pan, J., Shao, G., Shi, G., Guanyu, Z., Shi, Y., & Li, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0362586
Schmitt, C. (2020) · MACAU: Open Access Repository of Kiel University (University Library Kiel)
Mendes, I., Marques, L., Ribeiro, E., & Vale, N. (2026) · Physchem · doi:10.3390/physchem6010017
“The concept of drug combinations has garnered significant attention as a potential strategy for addressing complex diseases such as cancer, inflammation, and type 2 diabetes [67–69].”
Targeted squalenoyl nanomedicines for pancreatic cancer treatment
Valetti, S. (2014) · theses.fr (ABES) · doi:10.70675/e07f0115ze7abz481az8ec1zee1ef11b8348
Identification of novel therapeutic strtegies for Uveal Melanoma
Amirouchene-Angelozzi, N. (2014) · theses.fr (ABES) · doi:10.70675/a4c68596z2fdcz4da7z821bz5a92ef0821d0
Ariey-Bonnet, J. (2020) · theses.fr (ABES) · doi:10.70675/63ceaea1ze673z40c3z9960zed4c40d88ea9
Molins, E. A. G. (2020) · theses.fr (ABES) · doi:10.70675/252d1be2z22e8z4378zb146zfd4ec7fa46a7
Méthodes bayésiennes pour les études cliniques et pré-cliniques en onco-hématologie
Boumendil, L. (2024) · theses.fr (ABES) · doi:10.70675/37576af9zaf7dz4bf3za505z6043f0aca524
Computational Pipelines for Disease-Specific Drug Repurposing
Abdelsayed, M. (2026) · Pharmaceutical science. · doi:10.5772/intechopen.1015541
Sub-hypergraph encoding with Mamba-based feature refinement for drug synergy prediction
Sun, Y., Tong, J., Ding, L., & Li, L. (2026) · Expert Systems with Applications · doi:10.1016/j.eswa.2026.134873
BindingDB Entry 50020579: Design and Development of IKZF2 and CK1α Dual Degraders.
BindingDB (2024) · UC San Diego · doi:10.7270/q2q81jj2
BindingDB Entry 50043566: Polypharmacology - foe or friend?
BindingDB (2014) · UC San Diego · doi:10.7270/q28c9xpf
BindingDB (2023) · UC San Diego · doi:10.7270/q24f1vnk
BindingDB Entry 50037621: Designed multiple ligands. An emerging drug discovery paradigm.
BindingDB (2012) · UC San Diego · doi:10.7270/q2sf2wz9
BindingDB (2020) · UC San Diego · doi:10.7270/q2nc63v1
BindingDB Entry 50038080: Multi-target-directed ligands to combat neurodegenerative diseases.
BindingDB (2012) · UC San Diego · doi:10.7270/q25b039w
The impact of genetic interactions in antibiotic resistance
Trindade, S. I. G. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Network Pharmacology: An Emerging Area in Anti-Cancer Drug Discovery
Azmi, A. S., Beck, F. W. J., Bao, B., Sarkar, F. H., & Mohammad, R. M. (2012) · Springer eBooks · doi:10.1007/978-94-007-4819-4_17
Metadata
- Authors
- Keith, C. T., Borisy, A. A., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Corresponding author
- Keith, Curtis T.
- Borisy, Alexis A.
- Stockwell, Brent R.
- ORCID
- Stockwell, Brent R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-01
- Volume
- 4
- Issue
- 1
- Pages
- 71-78
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1592483428
- Cited by
- 769
- References
- 67
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 30 · 2023: 33 · 2022: 44 · 2021: 36 · 2020: 34 · 2019: 36 · 2018: 42 · 2017: 29 · 2016: 43 · 2015: 51 · 2014: 55 · 2013: 49 · 2012: 47
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- combination therapy, systems biology, mechanism of action, drug discovery
- MeSH terms
- Clinical Trials as Topic, Drug Synergism, Drug Therapy, Combination, Humans, Terminology as Topic, Drug Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.